Vanda Pharmaceuticals
VNDA
VNDA
99 hedge funds and large institutions have $348M invested in Vanda Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 44 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
13% more funds holding
Funds holding: 88 → 99 (+11)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
99
Holding in Top 10
–
Calls
$40.3M
Puts
$20M
Top Buyers
| 1 | +$26M | |
| 2 | +$13.7M | |
| 3 | +$9.51M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$9.03M |
| 5 |
DM
Deerfield Management
New York
|
+$8.98M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$8.15M | |
| 3 | -$7.88M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.04M |
| 5 |
VM
VHCP Management
New York
|
-$3.25M |